The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALLERGAN PLC SHS G0177J108 591,341 2,432,603 SH   SOLE   2,432,603 0 0
AMERICAN INTL GROUP INC *W EXP 01/19/202 026874156 7,479 354,812 SH   SOLE   354,812 0 0
ANTERO RES CORP COM 03674X106 457,505 21,170,996 SH   SOLE   21,170,996 0 0
ATARA BIOTHERAPEUTICS INC COM 046513107 75,035 5,359,632 SH   SOLE   5,359,632 0 0
AVIS BUDGET GROUP COM 053774105 109,080 4,000,000 SH   SOLE   4,000,000 0 0
CARDINAL HEALTH INC COM 14149Y108 158,178 2,030,000 SH   SOLE   2,030,000 0 0
CASCADIAN THERAPEUTICS INC COM NEW 14740B606 32,399 8,721,079 SH   SOLE   8,721,079 0 0
CENTENNIAL RESOURCE DEV INC CL A 15136A102 36,743 2,407,153 SH   SOLE   2,407,153 0 0
CHENIERE ENERGY INC COM NEW 16411R208 1,009,580 20,726,340 SH   SOLE   20,726,340 0 0
CHIPMOS TECHNOLOGIES INC SPONSORED ADR 16965P103 69,390 3,509,858 SH   SOLE   3,509,858 0 0
COLONY NORTHSTAR INC CL A COM 19625W104 674,988 47,905,461 SH   SOLE   47,905,461 0 0
CONYERS PK ACQUISITION *W EXP 07/20/202 212894117 3,242 1,237,500 SH   SOLE   1,237,500 0 0
CONYERS PK ACQUISITION CL A COM 212894109 43,733 3,712,500 SH   SOLE   3,712,500 0 0
CREDIT ACCEP CORP MICH COM 225310101 25,380 98,700 SH   SOLE   98,700 0 0
DELL TECHNOLOGIES INC COM CL V 24703L103 345,422 5,652,459 SH   SOLE   5,652,459 0 0
EXPRESS SCRIPTS HLDG CO COM 30219G108 163,232 2,556,891 SH   SOLE   2,556,891 0 0
FORWARD PHARMA A/S SPONSORED ADR 34986J105 129,381 6,364,059 SH   SOLE   6,364,059 0 0
GTY TECHNOLOGY HOLDINGS INC UNIT 99/99/9999 G4182A110 46,024 4,400,000 SH   SOLE   4,400,000 0 0
KERYX BIOPHARMACEUTICALS INC COM 492515101 186,474 25,791,678 SH   SOLE   25,791,678 0 0
LIBERTY MEDIA CORP DELAWARE COM C BRAVES GRP 531229888 31,244 1,303,482 SH   SOLE   1,303,482 0 0
NOVAGOLD RES INC COM NEW 66987E206 43,320 9,500,000 SH   SOLE   9,500,000 0 0
OREXIGEN THERAPEUTICS INC COM NEW 686164302 6,458 2,226,839 SH   SOLE   2,226,839 0 0
PARATEK PHARMACEUTICALS INC COM 699374302 57,707 2,394,498 SH   SOLE   2,394,498 0 0
PBF ENERGY INC CL A 69318G106 350,020 15,724,175 SH   SOLE   15,724,175 0 0
QORVO INC COM 74736K101 569,880 9,000,000 SH   SOLE   9,000,000 0 0
QUALCOMM INC COM 747525103 288,028 5,216,000 SH   SOLE   5,216,000 0 0
SABAN CAP ACQUISITION CORP *W EXP 09/21/202 78516C114 1,454 1,163,250 SH   SOLE   1,163,250 0 0
SABAN CAP ACQUISITION CORP COM CL A 78516C106 23,265 2,326,500 SH   SOLE   2,326,500 0 0
SILVER RUN ACQUISITION COM CL A 82812A103 67,016 6,615,552 SH   SOLE   6,615,552 0 0
SILVER RUN ACQUISITION W EXP 03/28/202 82812A111 3,953 2,205,184 SH   SOLE   2,205,184 0 0
SPIRIT RLTY CAP INC NEW COM 84860W102 66,690 9,000,000 SH   SOLE   9,000,000 0 0
SUNRUN INC COM 86771W105 20,278 2,848,082 SH   SOLE   2,848,082 0 0
SYNCHRONY FINL COM 87165B103 873,578 29,295,030 SH   SOLE   29,295,030 0 0
THERAVANCE BIOPHARMA INC COM G8807B106 369,476 9,273,991 SH   SOLE   9,273,991 0 0
THERAVANCE BIOPHARMA INC NOTE 3.250%11/0 88339KAA0 40,388 30,000,000 PRN   SOLE   30,000,000 0 0
THERAVANCE INC NOTE 2.125% 1/1 88338TAB0 15,462 16,980,000 PRN   SOLE   16,980,000 0 0
TRILOGY METALS INC NEW COM 89621C105 6,697 10,600,758 SH   SOLE   10,600,758 0 0
TWENTY FIRST CENTY FOX INC CL A 90130A101 542,356 19,137,469 SH   SOLE   19,137,469 0 0
TWENTY FIRST CENTY FOX INC CL B 90130A200 202,841 7,278,100 SH   SOLE   7,278,100 0 0
VERITIV CORP COM 923454102 136,997 3,044,385 SH   SOLE   3,044,385 0 0
VIASAT INC COM 92552V100 871,069 13,158,137 SH   SOLE   13,158,137 0 0